Aptevo Therapeutics (APVO) Prepaid Assets (2015 - 2026)
Aptevo Therapeutics (APVO) posted Prepaid Assets of $1.5 million for Q1 2026, little changed sequentially from $1.5 million in Q4 2025, and up 8.23% YoY from $1.3 million in Q1 2025.
Aptevo Therapeutics (APVO) Prepaid Assets (2015 - 2026) Analysis & Trends
Aptevo Therapeutics has reported Prepaid Assets for 12 years, with the latest figure at $1.5 million in Q1 2026.
- Quarterly Prepaid Assets rose 8.23% year-over-year to $1.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.5 million (up 8.23% YoY) and the FY2025 annual result came in at $1.5 million, up 43.33% from the prior year.
- Prepaid Assets steadied at $1.5 million in Q1 2026 per APVO's latest filing, from $1.5 million in the prior quarter.
- Over five years, Prepaid Assets peaked at $1.6 million in Q2 2025 and troughed at $77000.0 in Q3 2025.
- A 5-year average of $961529.4 and a median of $768000.0 in 2022 frame the typical range for Prepaid Assets.
- The sharpest annual moves came in 2022 and 2025: Prepaid Assets jumped 1063.64% in 2022, then sank 87.66% in 2025.
- Over 5 years, Prepaid Assets stood at $744000.0 in 2022, then dropped by 7.39% to $689000.0 in 2023, then soared by 48.04% to $1.0 million in 2024, then surged by 43.33% to $1.5 million in 2025, then dropped by 0.21% to $1.5 million in 2026.
- According to Business Quant data, Prepaid Assets over the past three periods registered $1.5 million, $1.5 million, and $77000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Aptevo Therapeutics | 3.18 Mn | -6.61 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.00 Mn |
| Mar 31, 2026 | 1.46 Mn |
| Dec 31, 2025 | 1.46 Mn |
| Sep 30, 2025 | 77,000.00 |
| Jun 30, 2025 | 1.59 Mn |
| Mar 31, 2025 | 1.35 Mn |
| Dec 31, 2024 | 1.02 Mn |
| Sep 30, 2024 | 624,000.00 |
| Jun 30, 2024 | 798,000.00 |
| Mar 31, 2024 | 691,000.00 |
| Dec 31, 2023 | 689,000.00 |
| Sep 30, 2023 | 649,000.00 |
| Jun 30, 2023 | 764,000.00 |
| Mar 31, 2023 | 1.58 Mn |
| Dec 31, 2022 | 744,000.00 |
| Sep 30, 2022 | 658,000.00 |
| Jun 30, 2022 | 768,000.00 |
| Mar 31, 2022 | 1.43 Mn |
| Dec 31, 2021 | 1.82 Mn |
| Sep 30, 2021 | 2.39 Mn |